Concepedia

Serological Assay Optimization

Serological Assay Optimization is a methodological process that systematically refines the biochemical and analytical parameters of serological assays to enhance their sensitivity, specificity, and reproducibility in detecting specific antibodies or antigens.

32

Publications

1.4K

Citations

293

Authors

113

Institutions

Publications per year

2017–2026

9

Parents

Publications

32

Suppression of non-specific binding in serological Luminex assays

Tim Waterboer, Peter Sehr, Michael Pawlita · Journal of Immunological Methods · 2005 · 284 citations

, , +8

An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera

Laura Couzens, Jin Gao, Kim B. Westgeest et al. · Journal of Virological Methods · 2014 · 202 citations · Full text

, , +16

SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity

Patricia K. Krause, Özlem Türeci, Patrick Micke et al. · Journal of Immunological Methods · 2003 · 120 citations

, , +12

Serodiagnosis of Mycobacterium bovis infection in badgers: development of an indirect ELISA using a 25 kDa antigen

J. Goodger, Ann Nolan, Wayne Russell et al. · Veterinary Record · 1994 · 87 citations

, , +17

Development of a virus neutralisation test to detect antibodies against Schmallenberg virus and serological results in suspect and infected herds

W.L.A. Loeffen, S. Quak, Els de Boer-Luijtze et al. · Acta veterinaria Scandinavica · 2012 · 85 citations · Full text

, , +17

1–5 of 32

Authors

293

  1. IU
    Itziar Ubillos

    Barcelona Institute for Global Health, Spain

    1 publications · 22 citations

    1

    h-index

  2. PC
    Philippe Chafey

    Inserm, France

    1 publications · 10 citations

    1

    h-index

  3. ME
    Margaret E. Conner

    Baylor College of Medicine, United States

    1 publications · 13 citations

    1

    h-index

  4. LJ
    Laura J. Hughes

    Centers for Disease Control and Prevention, United States

    1 publications · 17 citations

    1

    h-index

  5. KE
    Karen E. Kulas

    New York State Department of Health, United States

    1 publications · 24 citations

    1

    h-index

1–5 of 293

Institutions

113

  1. Novartis (Italy)

    Milan, Italy

    2 h-index

    21 publications

    972 citations

  2. Université Paris Cité

    Paris, France

    2 h-index

    3 publications

    42 citations

  3. Centers for Disease Control and Prevention

    Atlanta, United States

    2 h-index

    12 publications

    231 citations

  4. Inserm

    Paris, France

    2 h-index

    11 publications

    122 citations

  5. Toscana Life Sciences

    Siena, Italy

    2 h-index

    8 publications

    124 citations

  6. Sorbonne Paris Cité

    Paris, France

    2 h-index

    3 publications

    42 citations

  7. Novartis (Switzerland)

    Basel, Switzerland

    2 h-index

    14 publications

    838 citations

  8. AstraZeneca (Sweden)

    Södertälje, Sweden

    1 h-index

    1 publications

    37 citations

1–8 of 113

Venues

  1. Journal of Immunological Methods

    4 publications · 427 citations

    4

    h-index

  2. Journal of Virological Methods

    3 publications · 231 citations

    3

    h-index

  3. PLoS ONE

    2 publications · 27 citations

    2

    h-index

  4. Biologicals

    2 publications · 35 citations

    2

    h-index

  5. Journal of Clinical Microbiology

    JCM · 2 publications · 74 citations

    2

    h-index

1–5